You are here
- Home
- Therapy Areas
Respiratory/Inflammation
The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials. For more information on both of these therapy areas please click here.
- collapse Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients (Sweapea)
- collapse A Phase 1, Double-Blind, Randomized, Single Ascending Dose Study of the Safety and Tolerability of MEDI-570 in Systemic Lupus Erythematosus
- collapse A randomised, double-blind, placebo and active controlled, multi-centre, 6 way cross-over, single-dose Phase IIa study to investigate the local and systemic effects of 3 different doses of inhaled AZD2115 in patients with chronic obstructive pulmonary disease (COPD)
- collapse Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis (STRATUS)
- collapse Asthma Control Study 2011
- collapse A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Efficacy and Safety of CAM-3001 in Subjects with Rheumatoid Arthritis
- collapse A Phase 1, Randomized, Double-Blind, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557, a Humanized Monoclonal Antibody with an Extended Half-Life against Respiratory Syncytial Virus (RSV), in Healthy Adults
- collapse A Phase 1 Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Single and Multiple Intravenous Doses of MEDI-546, a Fully Human Monoclonal Antibody Directed Against Subunit 1 of the Type 1 Interferon Receptor, in Adult Subjects with Scleroderma
- collapse A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose, Intravenously Administered MEDI-545, a Fully Human Anti-Interferon-Alpha Monoclonal Antibody, in Patients with Chronic Plaque Psoriasis
- collapse Validation of questionnaire and assessment of patient satisfaction for budesonide/formoterol fix combination DPI in COPD
